Showing results (51-60 of 639) with videos related to
Sort By:
Pageof 64
Expert Opinion on Drug Safety|February 25, 2009
Glucocorticoids and the risk of osteoporosisLiron Caplan, Kenneth G SaagArthritis & Rheumatology (Hoboken, N.J.)|April 11, 2025
Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in OsteoporosisGiovanni Adami, Kenneth G SaagCurrent Women'S Health Reports|September 10, 2003
Osteoporosis: evaluation and treatmentSonia Bajaj, Kenneth G SaagCurrent Opinion in Rheumatology|May 3, 2019
Glucocorticoid-induced osteoporosis updateGiovanni Adami, Kenneth G SaagReviews in Endocrine & Metabolic Disorders|October 18, 2006
Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates?Sumapa Chaiamnuay, Kenneth G SaagCurrent Rheumatology Reports|May 25, 2019
Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid ArthritisGiovanni Adami, Kenneth G SaagArthritis Research & Therapy|October 24, 2009
Progress in osteoporosis and fracture prevention: focus on postmenopausal womenKenneth G Saag, Piet GeusensRheumatic Diseases Clinics of North America|November 28, 2015
Glucocorticoid-induced OsteoporosisXena Whittier, Kenneth G SaagArthritis Research & Therapy|July 6, 2006
Epidemiology, risk factors, and lifestyle modifications for goutKenneth G Saag, Hyon ChoiBest Practice & Research. Clinical Rheumatology|November 8, 2022
Risk for osteoporosis and fracture with glucocorticoidsMariana Urquiaga, Kenneth G SaagPageof 64